Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Debt to Equity (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Debt to Equity readings, the most recent being $0.66 for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 39.02% to $0.66 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.66, a 39.02% increase, with the full-year FY2025 number at $0.66, up 39.02% from a year prior.
  • Debt to Equity hit $0.66 in Q4 2025 for Treace Medical Concepts, up from $0.62 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.87 in Q4 2022 to a low of -$42.74 in Q1 2021.
  • Median Debt to Equity over the past 5 years was $0.45 (2024), compared with a mean of -$1.67.
  • Biggest five-year swings in Debt to Equity: tumbled 99.21% in 2021 and later surged 181.03% in 2022.
  • Treace Medical Concepts' Debt to Equity stood at $0.32 in 2021, then skyrocketed by 176.01% to $0.87 in 2022, then crashed by 55.87% to $0.38 in 2023, then grew by 22.87% to $0.47 in 2024, then skyrocketed by 39.02% to $0.66 in 2025.
  • The last three reported values for Debt to Equity were $0.66 (Q4 2025), $0.62 (Q3 2025), and $0.56 (Q2 2025) per Business Quant data.